From the idea to the project
From the project to the product
Tablets, creams, or suppositories: the correct form of administration is vital so that the active ingredient gets quickly, reliably, and with as few side effects as possible to the place where it is needed. Our Galenic Development Department in Konstanz is equipped with pilot machinery for the production of all popular forms of administration – even for highly effective drugs and hormones. To ensure that the most promising recipes can be identified early, each stage of development is monitored by our Analytic Development Department by means of an extensive spectrum of test procedures. As a result not only drugs, but also medical products and new packaging solutions are developed in our Galenic Department. In the area of biotechnology our special active ingredient bacterial culture suspension (BCS) undergoes continual further development.
As soon as a newly developed product is ready to meet the pharmaceutical requirements of an easy to produce and sustainable drug formula, samples are produced for clinical tests in the Galenic Development Department. These tests on the tolerance, availability, and effectiveness are then looked after by our Clinical Research Department.
From the product to the registered drug
Parallel to the extensive development work our internationally experienced Regulatory Affairs Department lays the foundations for later market licensing are laid by. For this purpose the responsible official offices in various states are provided with extensive data about the assessment according to the respectively valid requirements.
That way, in recent years products such as Cliovelle, KadeFungin Milchsäurekur, and Posterisan protect have been successfully developed from the idea phase to the market maturity. Apart from these newly development products, many drugs such as OeKolp, KadeFungin, and Posterisan which have enjoyed success in Germany have also been licensed in various countries around the world.